US Patent Issued to MINORYX THERAPEUTICS on July 7 for "Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-ylethoxyphenylmethyl-1,3-thiazolidine-2,4-dione" (Spanish, British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,048, issued on July 7, was assigned to MINORYX THERAPEUTICS S.L. (Mataro Barcelona, Spain).

"Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-ylethoxyphenylmethyl-1,3-thiazolidine-2,4-dione" was invented by Marc Martinell Pedemonte (Mataro Barcelona, Spain), Maria Pilar Pizcueta Lalanza (Mataro Barcelona, Spain), Guillem Pina Laguna (Mataro Barcelona, Spain), Uwe Meya (Mataro Barcelona, Spain) and Alan Bye (Horsham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating a disease or disorder in a patient comprising administering 5-[[4-[2-[5-(1...